Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership52,410 shares
Latest Disclosed Value $ 671,897
Creative Planning reports 31.71% increase in ownership of NTLA / Intellia Therapeutics, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 52,410 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $671,896 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 39,793 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 31.71% during the quarter. The current value of the position is $773,048 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 52,410 12,617 31.71 672 87.96 0.0004
2026-02-17 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 39,793 4,060 11.36 358 -42.14 0.0003
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 35,733 2,631 7.95 617 99.03 0.0005
2025-08-08 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 33,102 3,795 12.95 310 49.04 0.0003
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 29,307 8,144 38.48 208 -15.45 0.0002
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 21,163 8,618 68.70 247 -4.28 0.0002
2024-10-11 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 12,545 211 1.71 258 -6.88 0.0003
2024-08-15 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 12,334 -5,094 -29.23 276 -42.38 0.0003
2024-05-13 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 17,428 8,456 94.25 479 75.46 0.0005
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 8,972 8,757 4,073.02 274 4,450.00 0.0005
2023-11-16 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 215 215 7 0.0000
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -215 -100.00 0 -100.00
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 215 215 16 0.0000
2022-02-11 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -1,810 -100.00 0 -100.00
2021-11-10 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,810 1,810 243 0.0004
2020-07-23 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -63,561 -100.00 0 -100.00
2020-05-05 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 63,561 -20,353 -24.25 777 -36.88 0.0028
2020-01-30 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 83,914 401 0.48 1,231 10.40 0.0037
2019-11-01 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 83,513 -610 -0.73 1,115 -19.03 0.0036
2019-07-26 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 84,123 6,100 7.82 1,377 3.30 0.0046
2019-04-24 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 78,023 491 0.63 1,333 25.99 0.0048
2019-02-12 2018-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 77,532 -359 -0.46 1,058 -52.53 0.0043
2019-02-01 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 77,532 -359 1,058
2018-10-25 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 77,891 -469 -0.60 2,229 3.96 0.0083
2018-07-20 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 78,360 29,430 60.15 2,144 107.75 0.0084
2018-04-18 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 48,930 480 0.99 1,032 10.85 0.0042
2018-01-17 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 48,450 37,035 324.44 931 227.82 0.0040
2017-10-17 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 11,415 8,415 280.50 284 491.67 0.0013
2017-07-12 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,000 0 0.00 48 14.29 0.0002
2017-04-07 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 3,000 3,000 42 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.